PHARMATHER HLDGS LTD by PharmaTher Holdings Ltd. Financials - Benzinga

PHARMATHER HLDGS LTD by PharmaTher Holdings Ltd.

PHRRFOTCQB

Trade with Public

Trade with Public

$0.0400

-0.0029-6.76%

At close: Aug 28, 5:00 PM EST

Overview NewsFinancialsSentiment Compare

PHARMATHER HLDGS LTD by PharmaTher Holdings Ltd. Financials

PHARMATHER HLDGS LTD by PharmaTher Holdings Ltd. (PHRRF) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Psyched: A $100M Donation Pledge, Frank Biden Gets Candid, New Search Trends & More

World's Largest Psychedelics Conference Boasts 12K Attendees

Lara Goldstein

BetterLife Fast Tracks Its US Patent For Non-Hallucinogenic Compound And Other LSD Derivatives

Psychedelics biotech BetterLife Pharma Inc. (OTCQB: BETRF) is fast-tracking its U.S.

Lara Goldstein

Ketamine News: PharmaTher Begins FDA Filing For KETARX Application, Stella Acquires Field Trip Assets

Specialty biotech company PharmaTher Holdings Ltd. (OTCQB: PHRRF) has filed a pre-submission facility correspondence in advance of its Abbreviated New Drug Application (ANDA) for its novel racemic ketamine KETARX to the FDA.

Lara Goldstein

PharmaTher Seeks Regulatory Approval Of New Ketamine Delivery System For Anesthesia And Sedation

Specialty ketamine company PharmaTher Holdings Ltd.

Lara Goldstein

Psyched: States With Psychedelics Legalization Bills, Next-Gen Molecule For Addiction Treatment And More

Legalizing Psychedelics From New York To Washington And Five In Between: Which State Will Go First?

Lara Goldstein

2 Psychedelics Companies Tout Advanced Clinical Trials, Progress With Key Products

Two psychedelics companies have shared their updates and key milestones to be reached this 2023.

Lara Goldstein